Abstract:Purpose Esophageal cancer is the most common gastrointestinal tumor and is difficult to be eradicated with conventional treatment. Porphyrin-based photosensitizers (PSs) mediated photodynamic therapy (PDT) could kill tumor cells with less damage to normal cells. As the most widely used porphyrin-based photosensitizer in clinics, Photofrin II has excellent anti-tumor effect. However, it has some disadvantages such as weak absorption at near infrared region, the complexity of components and prolonged skin photosensitivity. Here series novel 5,15-diaryl-10,20-dihalogeno porphyrin derivatives were afforded and evaluated to develop more effective and safer photosensitizers for tumor therapy. Methods The photophysical properties and singlet oxygen generation rates of 5,15-diaryl-10,20-dihalogeno porphyrins ( I 1-6 , II 1-4 ) were tested. The cytotoxicity of I 1-6 and II 1-4 were measured by MTT assay. The pathway of cell death was studied by flow cytometry. In vivo photodynamic efficacy of I 3 and II 2-4 in Eca-109 tumor-bearing BABL/c nude mice were measured and histopathological analysis were examined. Results 5,15-Diaryl-10,20-dihalogeno porphyrins I 1-6 and II 1-4 were synthesized. The longest absorption wavelength of these halogenated porphyrins ( λ max = 660 nm) displayed a red shift around 30 nm compared to the unhalogenated porphyrins PS 1 ( λ max = 630 nm). The singlet oxygen generation rates of I 1-6 and II 1-4 were significantly higher than PS 1 and HMME. All PSs mediated PDT showed obvious cytotoxic effect against Eca-109 cells compared to HMME in vitro and in vivo. Among these PSs, II 4 exhibited appropriate absorption in the phototherapeutic window, higher 1 O 2 generation rate ( k = 0.0061 s −1 ), the strongest phototoxicity (IC 50 = 0.4 μM), lower dark toxicity, high generation of intracellular ROS in Eca-109 cells and excellent photodynamic anti-tumor efficacy in vivo. Besides, cell necrosis was induced by compound II 4 mediated PDT. Conclusion All new compounds have obvious photodynamic anti-esophageal cancer effects. Among them, the photosensitizer II 4 showed excellent efficacy in vitro and in vivo, which has the potential to become a photodynamic anti-tumor drug.

Hydroxy-corrole and its gallium(III) complex as new photosensitizer for photodynamic therapy against breast carcinoma

Halogenated Gallium Corroles:DNA Interaction and Photodynamic Antitumor Activity

Photodynamic antitumor activity of Gallium(III) and Phosphorus(V) complexes of trimethoxyl A2B triaryl corrole

Methyl Benzoate Gallium(III) Corrole Complexes: DNA‐binding, Photocleavage Activity, Cytotoxicity on Tumor Cells

Hydrazone-Functionalized trans-A2B-Corroles: Effective Synergy in Photodynamic Therapy of Lung Cancer

Targeted photodynamic therapy of cancer using a novel gallium (III) tris (ethoxycarbonyl) corrole conjugated-mAb directed against cancer/testis antigens 83.

Synthesis, singlet oxygen generation, photocytotoxicity and subcellular localization of azobisporphyrins as potentially photodynamic therapeutic agents in vitro cell study

Azide-modified corrole phosphorus complexes for endoplasmic reticulum-targeted fluorescence bioimaging and effective cancer photodynamic therapy

Construction of 5-Fluorouracil and Gallium Corrole Conjugates for Enhanced Photodynamic Therapy

Synthesis of three new copper(II) compounds for chemodynamic therapy against cancer cells

Anticancer activity and mechanism studies of photoactivated iridium(III) complexes toward lung cancer A549 cells

The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy

Hydrazone-Functionalized trans -A 2 B-Corroles: Effective Synergy in Photodynamic Therapy of Lung Cancer

Meso-substituted Porphyrin Photosensitizers with Enhanced Near-Infrared Absorption: Synthesis, Characterization and Biological Evaluation for Photodynamic Therapy

Dendron‐Functionalized Polyglutamate‐Pyropheophorbide‐a Conjugates as Nanomedicines for Breast Cancer Photodynamic Therapy

Synthesis and dual fluorescence property of novel dihydroxy phosphorus tetrabenzotriazacorrole derivates

Quaternary ammonium cations conjugated 5,15-diaryltetranaphtho[2,3]porphyrins as photosensitizers for photodynamic therapy

Synthesis and evaluation of new fluorinated pyropheophorbide-a derivatives for photodynamic therapy

Synthesis and evaluation of novel fluorinated hematoporphyrin ether derivatives for photodynamic therapy

Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy

A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent